Caleres Is Taking A Step In The Right Direction (Rating Upgrade)
Caleres (CAL) Price Target Decreased by 11.76% to 15.30
Caleres, Inc. (CAL) Q4 2025 Earnings Call Transcript
Caleres Is Now Reasonably Priced, But Is Not Attractive After The Rally
Caleres, Inc. 2026 Q4 - Results - Earnings Call Presentation
Caleres, Inc. (CAL) Q4 2026 Earnings Call Transcript
Caleres shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 adjusted EPS guidance above estimates.
Stuart Weitzman-Parent Caleres Stock Pops As E-Commerce Strength Drives Growth
Caleres Sees Q1 2026 GAAP EPS $0.21-$0.26 vs $0.28 Est
Caleres Sees Q1 2026 Adj EPS $0.25-$0.30 vs $0.20 Est, With Net Sales Up Mid To High-Single Digits
Caleres Sees FY2026 GAAP EPS $1.31-$1.61 vs $1.74 Est
Caleres Sees FY2026 Adj EPS $1.35-$1.65 vs $1.51 Est, With Net Sales Up Low To Mid-Single Digits
Caleres Q4 2025 Adj. EPS $(0.36) Beats $(0.40) Estimate, Sales $695.062M Beat $679.649M Estimate
Caleres, VF Corp, Funko, ThredUp, and Stitch Fix Stocks Trade Down, What You Need To Know
Caleres, PVH, Under Armour, Carter's, and Kontoor Brands Shares Are Soaring, What You Need To Know
June Ambrose Creates STYLE-LETICS, a Sport-Infused Shoe Capsule for Naturalizer
Kristen Sosa Joins Caleres as Division President of New York Brands
CalciMedica shares are trading lower after the company announced the discontinuation of its Phase 2 KOURAGE clinical trial.
Caleres Names Interim CFO as It Grapples With Saks Global Bankruptcy Impacts
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.